Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 7 of 15
Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth
NCT03135990
PET Measures of CSF Clearance in Preclinical Alzheimer's Disease
NCT03663387
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)
NCT03653611
Food Order Intervention for Gestational Diabetes
NCT03592784
The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination
NCT03367429
Clinical Validation of New Commercial Sleep Monitoring Devices
NCT02779543
CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
NCT03542266
HIPEC After Radical Cystectomy for High Risk Bladder Cancer
NCT03514888
177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC
NCT03545165
Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
NCT03439033
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
NCT03510988
Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block
NCT03138577
Trial of an Intervention to Improve Metformin Persistence and Adherence
NCT03467763
Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients
NCT03377855
A Behavioral Intervention for Depression and Chronic Pain in Primary Care
NCT03265210
A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)
NCT03333252
Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome
NCT03383107
YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03512184
EM/PROTECT: Improving Depression in Elder Mistreatment Victims
NCT03241225
Reaching and Engaging Depressed Senior Center Clients (REDS)
NCT03246789
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
NCT03632655
Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma
NCT03307395
Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
NCT03335267
Parent Video Feedback Intervention Study
NCT03397719
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
NCT03315286
Phase I Trial of 225Ac-J591 in Patients With mCRPC
NCT03276572
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
NCT03168464
Impact of Escitalopram on Sperm DNA Fragmentation
NCT03527043
The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery
NCT02875405
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
NCT03323437
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
NCT03522350
A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions
NCT03487822
To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
NCT03277209
Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients
NCT03276559
Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise
NCT03206905
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression
NCT03043573
Fertility Preservation- Oncology Treatment Effects and Psychological Impact
NCT02515916
PRISM 2.0 in Diverse Living Contexts
NCT03116399
A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making
NCT03156634
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
NCT03146962
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
NCT03026127
CleanUP IPF for the Pulmonary Trials Cooperative
NCT02759120
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
NCT03075202
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
NCT03536364
Mitochondrial DNA as a Biomarker of Sepsis Severity
NCT03077672
PSMA Imaging of Localized Prostate Cancer
NCT03675451
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
NCT03036904
Glymphatic Kinetics In Healthy Adult Volunteers
NCT03218111
Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis
NCT02734576
Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury
NCT04943835
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.